Comment on ‘Evidence Mapping of Clinical Practice Guidelines Recommendations and Quality for Nutritional Management in Dementia’

This commentary critically appraises the evidence‐mapping review by Su et al. on clinical practice guideline recommendations for nutritional management in dementia. Although the review provides a valuable synthesis using AGREE II and RIGHT checklist methodology, several interpretive limitations warrant attention before its recommendations are translated into practice. First, the included guidelines represent structurally distinct sources: dementia‐specific guidelines incorporating nutritional advice and nutrition‐focused guidelines extrapolating recommendations to dementia populations. Presenting these together without stratification may obscure whether recommendations are supported by dementia‐specific evidence. Second, the low AGREE II scores for applicability and rigour of development suggest that many recommendations may lack sufficient implementation guidance, particularly in domains requiring staffing, food‐service flexibility and allied‐health support. Third, the education recommendations arise only from two iterations of the same guideline source and are graded as weak, making them less evidentially robust than multi‐guideline recommendations in other domains. Finally, limited reporting of conflicts of interest is relevant because several recommendations involve commercially sensitive interventions such as oral nutritional supplements and enteral nutrition. Stratifying guideline type, qualifying recommendations by implementability and distinguishing single‐source weak recommendations would improve the clinical usefulness of the evidence map.